Unaltered SNARE complex formation in an in vivo model of prion disease

被引:13
作者
Asuni, Ayodeji A. [1 ]
Cunningham, Colm [1 ]
Vigneswaran, Piranavhan [2 ]
Perry, V. Hugh [1 ]
O'Connor, Vincent [1 ]
机构
[1] Univ Southampton, Sch Biol Sci, Southampton SO16 7PX, Hants, England
[2] Univ Southampton, Biomed Sci Undergrad Program, Southampton SO16 7PX, Hants, England
基金
英国医学研究理事会;
关键词
Prion; Hippocampus; Neurodegeneration; Synaptopathy; SNARE complex; Syntaxin; Neurotransmitter release;
D O I
10.1016/j.brainres.2008.07.083
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The ME7 model of prion disease is a chronic slowly evolving model of neurodegeneration in which cell death is preceded by synaptic dysfunction. Previous studies in cell culture show that accumulation of misfolded prion inhibits the formation of the SNARE complexes involving synaptobrevin, syntaxin and SNAP-25 that play an essential role in neurotransmitter release. Such observations suggest that similar phenomenon may contribute to synaptic dysfunction observed in vivo. We have thus used detergent extraction of hippocampal tissue to investigate the status of SNARE complexes in the ME7 model. In the presence of increasing PrPSc deposition we failed to see a change in the amount of SNARE complexes directly extracted into SDS and resolved by SDS-PAGE. Conversely pre-extraction in Triton X-100, a treatment that promotes SNARE complexes ex vivo, demonstrated a modest reduction in hippocampal SNARE complexes when homogenates were made from tissue at late stage disease. This suggests that accumulated PrPSc, or perhaps fibrillar complexes formed of prion only inhibit SNARE complexes that are formed ex vivo following biochemical extraction. Thus the accumulation of PrPSc although deleterious to synaptic function in vivo, does not exert its synaptic effects by disrupting the formation of SNARE complexes that are core to transmitter release. Crown Copyright (c) 2008 Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 32 条
[1]   GSK3α exhibits β-catenin and tau directed kinase activities that are modulated by Wnt [J].
Asuni, Ayodeji A. ;
Hooper, Claudie ;
Reynolds, C. Hugh ;
Lovestone, Simon ;
Anderton, Brian H. ;
Killick, Richard .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2006, 24 (12) :3387-3392
[2]   SYNTAXIN - A SYNAPTIC PROTEIN IMPLICATED IN DOCKING OF SYNAPTIC VESICLES AT PRESYNAPTIC ACTIVE ZONES [J].
BENNETT, MK ;
CALAKOS, N ;
SCHELLER, RH .
SCIENCE, 1992, 257 (5067) :255-259
[3]  
Betmouni S, 1999, NEUROPATH APPL NEURO, V25, P20, DOI 10.1046/j.1365-2990.1999.00153.x
[4]   INHIBITION OF NEUROTRANSMITTER RELEASE BY CLOSTRIDIAL NEUROTOXINS CORRELATES WITH SPECIFIC PROTEOLYSIS OF SYNAPTOSOMAL PROTEINS [J].
BLASI, J ;
BINZ, T ;
YAMASAKI, S ;
LINK, E ;
NIEMANN, H ;
JAHN, R .
JOURNAL OF PHYSIOLOGY-PARIS, 1994, 88 (04) :235-241
[5]   SCRAPIE AND CELLULAR PRION PROTEINS DIFFER IN THEIR KINETICS OF SYNTHESIS AND TOPOLOGY IN CULTURED-CELLS [J].
BORCHELT, DR ;
SCOTT, M ;
TARABOULOS, A ;
STAHL, N ;
PRUSINER, SB .
JOURNAL OF CELL BIOLOGY, 1990, 110 (03) :743-752
[6]   Protein misfolding, functional amyloid, and human disease [J].
Chiti, Fabrizio ;
Dobson, Christopher M. .
ANNUAL REVIEW OF BIOCHEMISTRY, 2006, 75 :333-366
[7]   An integrated, temporal study of the behavioural, electrophysiological and neuropathological consequences of murine prion disease [J].
Chiti, Z ;
Knutsen, OM ;
Betmouni, S ;
Greene, JRT .
NEUROBIOLOGY OF DISEASE, 2006, 22 (02) :363-373
[8]   Progress in pathogenesis studies of spinocerebellar ataxia type 1 [J].
Cummings, CJ ;
Orr, HT ;
Zoghbi, HY .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 1999, 354 (1386) :1079-1081
[9]   Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease [J].
Cunningham, C ;
Deacon, R ;
Wells, H ;
Boche, D ;
Waters, S ;
Diniz, CP ;
Scott, H ;
Rawlins, JNP ;
Perry, VH .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2003, 17 (10) :2147-2155
[10]   The synaptic vesicle protein CSPα prevents presynaptic degeneration [J].
Fernández-Chacón, R ;
Wölfel, M ;
Nishimune, H ;
Tabares, L ;
Schmitz, F ;
Castellano-Muñoz, M ;
Rosenmund, C ;
Montesinos, ML ;
Sanes, JR ;
Schneggenburger, R ;
Südhof, TC .
NEURON, 2004, 42 (02) :237-251